Literature DB >> 11836402

Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity.

Theresa Li-Yun Chang1, Cynthia J Gordon, Branka Roscic-Mrkic, Christine Power, Amanda E I Proudfoot, John P Moore, Alexandra Trkola.   

Abstract

The interaction of the CC-chemokine RANTES with its cell surface receptors transduces multiple intracellular signals: low concentrations of RANTES (1 to 10 nM) stimulate G-protein-coupled receptor (GPCR) activity, and higher concentrations (1 microM) activate a phosphotyrosine kinase (PTK)-dependent pathway. Here, we show that the higher RANTES concentrations induce rapid tyrosine phosphorylation of multiple proteins. Several src-family kinases (Fyn, Hck, Src) are activated, as is the focal adhesion kinase p125 FAK and, eventually, members of the p44/p42 mitogen-activated protein kinase (MAPK) family. This PTK signaling pathway can be activated independently of known seven-transmembrane GPCRs for RANTES because it occurs in cells that lack any such RANTES receptors. Instead, activation of the PTK signaling pathway is dependent on the expression of glycosaminoglycans (GAGs) on the cell surface, in that it could not be activated by RANTES in GAG-deficient cells. We have previously demonstrated that RANTES can both enhance and inhibit infection of cells with human immunodeficiency virus type 1 (HIV-1). Here we show that activation of both PTK and MAPK is involved in the enhancement of HIV-1 infectivity caused by RANTES in cells that lack GPCRs for RANTES but which express GAGs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836402      PMCID: PMC135942          DOI: 10.1128/jvi.76.5.2245-2254.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

Review 1.  Chemokine receptors and HIV.

Authors:  C C Broder; R G Collman
Journal:  J Leukoc Biol       Date:  1997-07       Impact factor: 4.962

2.  Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5.

Authors:  R J Nibbs; S M Wylie; I B Pragnell; G J Graham
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

3.  Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals.

Authors:  J F Krowka; M L Gesner; M S Ascher; H W Sheppard
Journal:  Clin Immunol Immunopathol       Date:  1997-10

4.  RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3.

Authors:  M C Szabo; E C Butcher; B W McIntyre; T J Schall; K B Bacon
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

Review 5.  Co-receptors for HIV-1 entry.

Authors:  J P Moore; A Trkola; T Dragic
Journal:  Curr Opin Immunol       Date:  1997-08       Impact factor: 7.486

6.  Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1alpha.

Authors:  W Koopmann; M S Krangel
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

7.  HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.

Authors:  A Amara; S L Gall; O Schwartz; J Salamero; M Montes; P Loetscher; M Baggiolini; J L Virelizier; F Arenzana-Seisdedos
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

8.  RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells.

Authors:  K B Bacon; M C Szabo; H Yssel; J B Bolen; T J Schall
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

9.  Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.

Authors:  R I Connor; K E Sheridan; D Ceradini; S Choe; N R Landau
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

10.  Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization.

Authors:  J M Serrador; J L Alonso-Lebrero; M A del Pozo; H Furthmayr; R Schwartz-Albiez; J Calvo; F Lozano; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

View more
  10 in total

1.  HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.

Authors:  Maria A De Francesco; Manuela Baronio; Claudio Poiesi
Journal:  J Biol Chem       Date:  2011-04-11       Impact factor: 5.157

2.  HIV-1 glycoprotein 41 ectodomain induces activation of the CD74 protein-mediated extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to enhance viral infection.

Authors:  Chang Zhou; Lu Lu; Suiyi Tan; Shibo Jiang; Ying-Hua Chen
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

3.  Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair.

Authors:  Haiyan Lu; Danping Huang; Richard M Ransohoff; Lan Zhou
Journal:  FASEB J       Date:  2011-06-22       Impact factor: 5.191

4.  Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

5.  CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.

Authors:  Gabriele S V Campanella; Richard A Colvin; Andrew D Luster
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

6.  Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates.

Authors:  Theresa L Chang; Arielle Klepper; Jian Ding; John Garber; Aprille Rapista; Arevik Mosoian; Wolfgang Hubner; Julio Gutierrez; Jose Walewski; Jeffrey Abergel; Thomas Schiano; Andrea Branch
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

7.  The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.

Authors:  Douglas P Dyer; Catherina L Salanga; Brian F Volkman; Tetsuya Kawamura; Tracy M Handel
Journal:  Glycobiology       Date:  2015-11-17       Impact factor: 4.313

8.  Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.

Authors:  Aprille Rapista; Jian Ding; Bernadette Benito; Yung-Tai Lo; Matthew B Neiditch; Wuyuan Lu; Theresa L Chang
Journal:  Retrovirology       Date:  2011-06-14       Impact factor: 4.602

Review 9.  The secret life of viral entry glycoproteins: moonlighting in immune evasion.

Authors:  Jonathan D Cook; Jeffrey E Lee
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

10.  HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.

Authors:  Anantha R Nookala; Ankit Shah; Richard J Noel; Anil Kumar
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.